Friday, July 25, 2008

Platelet wars contd.

Bayer's experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency.

Recommendations for marketing approval by CHMP are normally endorsed by the European Commission within a couple of months.

Ben Hirschler at Reuters


No comments: